Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1589-1600

  Gaspar, J M ^a,b   Baptista, F I ^a   Galvao J ^a   Castilho, A F ^a   Cunha, R A ^b,c   Ambrosio A F ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Diabetes; Exocytosis; Hippocampus; Nerve terminals; Retina; Synaptic proteins

Indexed keywords

MEMBRANE PROTEIN; RABPHILIN 3A; SYNAPSIN I; SYNAPTOBREVIN 2; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EXOCYTOSIS; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RETINA; STREPTOZOCIN DIABETES; SYNAPTOSOME;

EID: 77955414626     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.021     Document Type: Article

References (51)

1. Abderrahmani A., Plaisance V., Lovis P., Regazzi R. Mechanisms controlling the expression of the components of the exocytotic apparatus under physiological and pathological conditions. Biochem Soc Trans 2006, 34:696-700.
2. Antonetti D.A., Barber A.J., Bronson S.K., Freeman W.M., Gardner T.W., Jefferson L.S., Kester M., Kimball S.R., Krady J.K., LaNoue K.F., Norbury C.C., Quinn P.G., Sandirasegarane L., Simpson I.A. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55:2401-2411.
3. Artola A., Kamal A., Ramakers G.M., Biessels G.J., Gispen W.H. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci 2005, 22:169-178.
4. Barber A.J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:283-290.
5. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998, 102:783-791.
6. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45:1259-1266.
7. Bronk P., Deak F., Wilson M.C., Liu X., Sudhof T.C., Kavalali E.T. Differential effects of SNAP-25 deletion on Ca2+-dependent and Ca2+-independent neurotransmission. J Neurophysiol 2007, 98:794-806.
8. Ceccaldi P.E., Grohovaz F., Benfenati F., Chieregatti E., Greengard P., Valtorta F. Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: an analysis by videomicroscopy. J Cell Biol 1995, 128:905-912.
9. Chapman E.R. How does synaptotagmin trigger neurotransmitter release?. Annu Rev Biochem 2008, 77:615-641.
10. Corradi A., Zanardi A., Giacomini C., Onofri F., Valtorta F., Zoli M., Benfenati F. Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment. J Cell Sci 2008, 121:3042-3051.
11. Costa G., Pereira T., Neto A.M., Cristovao A.J., Ambrosio A.F., Santos P.F. High glucose changes extracellular adenosine triphosphate levels in rat retinal cultures. J Neurosci Res 2009, 87:1375-1380.
12. Daley M.L., Watzke R.C., Riddle M.C. Early loss of blue-sensitive color vision in patients with type I diabetes. Diabetes Care 1987, 10:777-781.
13. Daly C., Ziff E.B. Ca2+-dependent formation of a dynamin-synaptophysin complex: potential role in synaptic vesicle endocytosis. J Biol Chem 2002, 277:9010-9015.
14. Deak F., Shin O.H., Tang J., Hanson P., Ubach J., Jahn R., Rizo J., Kavalali E.T., Sudhof T.C. Rabphilin regulates SNARE-dependent re-priming of synaptic vesicles for fusion. EMBO J 2006, 25:2856-2866.
15. Duarte J.M., Carvalho R.A., Cunha R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem 2009, 111:368-379.
16. Duarte J.M., Oliveira C.R., Ambrosio A.F., Cunha R.A. Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem Int 2006, 48:144-150.
17. Fujiwara T., Mishima T., Kofuji T., Chiba T., Tanaka K., Yamamoto A., Akagawa K. Analysis of knock-out mice to determine the role of HPC-1/syntaxin 1A in expressing synaptic plasticity. J Neurosci 2006, 26:5767-5776.
18. Gastinger M.J., Singh R.S., Barber A.J. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 2006, 47:3143-3150.
19. Geppert M., Goda Y., Hammer R.E., Li C., Rosahl T.W., Stevens C.F., Sudhof T.C. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 1994, 79:717-727.
20. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
21. Grillo C.A., Piroli G.G., Wood G.E., Reznikov L.R., McEwen B.S., Reagan L.P. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 2005, 136:477-486.
22. Guyot L.L., Diaz F.G., O'Regan M.H., Song D., Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 2001, 48:385-390. discussion 390-391.
23. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat Rev Mol Cell Biol 2006, 7:631-643.
24. Kamal A., Biessels G.J., Gispen W.H., Ramakers G.M. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res 2006, 1073-1074:276-280.
25. Kamal A., Biessels G.J., Urban I.J., Gispen W.H. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 1999, 90:737-745.
26. Kirwin S.J., Kanaly S.T., Linke N.A., Edelman J.L. Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2009, 50:5396-5404.
27. Kurihara T., Ozawa Y., Nagai N., Shinoda K., Noda K., Imamura Y., Tsubota K., Okano H., Oike Y., Ishida S. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008, 57:2191-2198.
28. Leenders A.G., Sheng Z.H. Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol Ther 2005, 105:69-84.
29. Magarinos A.M., McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci U S A 2000, 97:11056-11061.
30. Martínez-Tellez R., Gómez-Villalobosa M.J., Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 2005, 1048:108-115.
31. McGirr R., Ejbick C.E., Carter D.E., Andrews J.D., Nie Y., Friedman T.C., Dhanvantari S. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells. Endocrinology 2005, 146:4514-4523.
32. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20. Mellitus. ECotDaCoD.
33. Misumi Y., Yamato T., Obata T., Aomine M. Effects of ion channel blockers on basal hippocampal monoamine levels in freely moving diabetic and non-diabetic rats. Int J Neurosci 2008, 118:761-780.
34. Miyata S., Yamada N., Hirano S., Tanaka S., Kamei J. Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice. Brain Res 2007, 1147:233-239.
35. Morris M.J., Pavia J.M. Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats. Brain Res 2004, 1006:100-106.
36. Ostenson C.G., Gaisano H., Sheu L., Tibell A., Bartfai T. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006, 55:435-440.
37. Reagan L.P., Magarinos A.M., McEwen B.S. Neurological changes induced by stress in streptozotocin diabetic rats. Ann N Y Acad Sci 1999, 893:126-137.
38. Roy M.S., Gunkel R.D., Podgor M.J. Color vision defects in early diabetic retinopathy. Arch Ophthalmol 1986, 104:225-228.
39. Sakai H., Tani Y., Shirasawa E., Shirao Y., Kawasaki K. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res 1995, 27:57-63.
40. Santiago A.R., Cristovao A.J., Santos P.F., Carvalho C.M., Ambrosio A.F. High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol Dis 2007, 25:464-472.
41. Santiago A.R., Pereira T.S., Garrido M.J., Cristovao A.J., Santos P.F., Ambrosio A.F. High glucose and diabetes increase the release of [3H]-d-aspartate in retinal cell cultures and in rat retinas. Neurochem Int 2006, 48:453-458.
42. Satoh E., Takahashi A. Experimental diabetes enhances Ca(2+) mobilization and glutamate exocytosis in cerebral synaptosomes from mice. Diabetes Res Clin Pract 2008, 81:e14-e17.
43. Shirasu M., Kimura K., Kataoka M., Takahashi M., Okajima S., Kawaguchi S., Hirasawa Y., Ide C., Mizoguchi A. VAMP-2 promotes neurite elongation and SNAP-25A increases neurite sprouting in PC12 cells. Neurosci Res 2000, 37:265-275.
44. Sorensen J.B., Nagy G., Varoqueaux F., Nehring R.B., Brose N., Wilson M.C., Neher E. Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23. Cell 2003, 114:75-86.
45. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
46. Sudhof T.C. Function of Rab3 GDP-GTP exchange. Neuron 1997, 18:519-522.
47. Takei Y., Harada A., Takeda S., Kobayashi K., Terada S., Noda T., Takahashi T., Hirokawa N. Synapsin I deficiency results in the structural change in the presynaptic terminals in the murine nervous system. J Cell Biol 1995, 131:1789-1800.
48. Trudeau F., Gagnon S., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004, 490:177-186.
49. Vanguilder H.D., Brucklacher R.M., Patel K., Ellis R.W., Freeman W.M., Barber A.J. Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina. Eur J Neurosci 2008, 28:1-11.
50. Yamato T., Misumi Y., Yamasaki S., Kino M., Aomine M. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 2004, 17:128-136.
51. Zhang W., Khan A., Ostenson C.G., Berggren P.O., Efendic S., Meister B. Down-regulated expression of exocytotic proteins in pancreatic islets of diabetic GK rats. Biochem Biophys Res Commun 2002, 291:1038-1044.